The State of AI in Pharmaceutical Drug Development
| This Forbes article was written following a lecture Dr. Niven R. Narain, Ph.D., BERG Co-Founder, President and CEO, gave at Harvard Medical School during the AI Applications Summit for BioPharma in October.
The conference provided a useful snapshot into what is happening at the intersection of AI and life sciences and the article describes the author’s ten key observations. To read the full article, click here. |